MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Perrigo Co PLC

Avatud

SektorTervishoid

24.86 0.44

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

24.43

Max

25.08

Põhinäitajad

By Trading Economics

Sissetulek

-24M

-45M

Müük

51M

1.1B

P/E

Sektori keskmine

2,570

57.333

Aktsiakasum

0.93

Dividenditootlus

4.76

Kasumimarginaal

-3.909

Töötajad

8,379

EBITDA

35M

114M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+38.61% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

4.76%

2.63%

Järgmine tulemuste avaldamine

7. mai 2025

Järgmine dividendimakse kuupäev

17. juuni 2025

Järgmine aktsia dividendi kuupäev (ex-date)

29. mai 2025

Turustatistika

By TradingEconomics

Turukapital

85M

3.5B

Eelmine avamishind

24.42

Eelmine sulgemishind

24.86

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Perrigo Co PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. veebr 2025, 17:42 UTC

Suurimad hinnamuutused turgudel

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27. veebr 2025, 23:52 UTC

Tulu

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Võrdlus sarnastega

Hinnamuutus

Perrigo Co PLC Prognoos

Hinnasiht

By TipRanks

38.61% tõus

12 kuu keskmine prognoos

Keskmine 34.5 USD  38.61%

Kõrge 42 USD

Madal 27 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Perrigo Co PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

2

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

24.825 / 25Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.